VistaGen Therapeutics, Inc. (VTGN) Social Stream
VISTAGEN THERAPEUTICS INC (VTGN) Price Targets From Analysts
Use the tables below to see what analysts covering VISTAGEN THERAPEUTICS INC think about its future price and what recommendations they have for investors and traders.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-10 | 2 | $8 | $5 | $6.5 | $5.45 | 19.27% |
| 2022-02-10 | 2 | $8 | $8 | $8 | $5.45 | 46.79% |
| 2022-07-22 | 3 | $0.25 | $0.2 | $0.225 | $5.45 | -95.87% |
| 2023-09-08 | 2 | $30 | $30 | $30 | $5.45 | 450.46% |
| 2023-10-20 | 2 | $12 | $12 | $12 | $5.45 | 120.18% |
| 2023-11-13 | 3 | $12 | $12 | $12 | $5.45 | 120.18% |
| 2023-12-07 | 4 | $15 | $12 | $13 | $5.45 | 138.53% |
| NA | 2 | $NA | $NA | $NA | $5.45 | NA% |
The Trend in the Analyst Price Target
VTGN's average price target has moved up $7.5 over the prior 35 months.
Over the past 122 days, VTGN's average upside potential has been 270.62%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-08-07 | 2 | 30 | 30 | 30 | 13.05 | 129.89% |
| 2023-09-08 | 2 | 30 | 30 | 30 | 6.74 | 345.1% |
| 2023-10-20 | 2 | 12 | 12 | 12 | 2.98 | 302.68% |
| 2023-11-13 | 4 | 12 | 12 | 12 | 2.73 | 339.56% |
| 2023-12-07 | 4 | 15 | 12 | 13 | 4.87 | 166.94% |
VTGN Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1 | 4 | 0 | 0 | 0 | 0 | 4 |
The Trend in the Broker Recommendations
Over the past 26 months, VTGN's average broker recommendation rating improved by 0.25.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- In terms of how VISTAGEN THERAPEUTICS INC fares relative to all US stocks, note that its number of analysts covering the stock is greater than 84.94% of that group.
- In the context of Pharmaceutical Products stocks, VISTAGEN THERAPEUTICS INC's variance in analysts' estimates is lower than -61.24% of them.
- VTGN has a greater average analyst price target than 166.1% of Healthcare stocks.
- VTGN has a greater upside potential (average analyst target price relative to current price) than 406.47% of stocks in the small market cap category.
Stocks similar to VISTAGEN THERAPEUTICS INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are CRMD, MDVL, and SLS.
View All Top Stocks by Price Target
Make investment decisions regarding VTGN using the data that counts. Try POWR Ratings for free.